Literature DB >> 7075428

Relationship between serum and biliary bile acids as an indicator of chenodeoxycholic and ursodeoxycholic acid-induced hepatotoxicity in the rhesus monkey.

F Bazzoli, A Roda, H Fromm, R P Sarva, E Roda, L Barbara.   

Abstract

The relationship between serum and biliary concentrations of bile acids was studied in 20 rhesus monkeys which developed hepatotoxicity after six months of treatment with 40 and 120 mg/kg/day doses of chenodeoxycholic (cheno) and ursodeoxycholic (urso) acids, respectively. During the treatment, lithocholate--all of which was unsulfated--increased several-fold both in serum and in bile. There was a significant correlation between serum and biliary concentrations of lithocholate. Similarly close correlations existed between the serum and biliary concentrations of the conjugates of cheno and urso which increased during treatment with the respective bile acids. The serum levels of cholate and deoxycholate remained normal, although their concentrations in bile decreased considerably during treatment with cheno and urso, respectively. Further studies have to establish whether serum determinations of lithocholate can also be used in man to study the role of this bile acid in the liver function abnormalities which develop in some patients treated with cheno or urso and/or whether measurement of serum cheno or urso could be useful for the monitoring of patient compliance with the respective bile acid treatment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7075428     DOI: 10.1007/bf01295650

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  34 in total

1.  Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones.

Authors:  J L Thistle; A F Hofmann
Journal:  N Engl J Med       Date:  1973-09-27       Impact factor: 91.245

2.  Metabolism of lithocholate in healthy man. II. Enterohepatic circulation.

Authors:  A E Cowen; M G Korman; A F Hofmann; O W Cass; S B Coffin
Journal:  Gastroenterology       Date:  1975-07       Impact factor: 22.682

3.  Altered drug metabolism and elevated serum bile acids in liver disease: a unified pharmacokinetic explanation.

Authors:  I T Gilmore; A F Hofmann
Journal:  Gastroenterology       Date:  1980-01       Impact factor: 22.682

4.  Metabolism of lithocholate in healthy man. III. Plasma disappearance of radioactivity after intravenous injection of labeled lithocholate and its derivatives.

Authors:  A E Cowen; M G Korman; A F Hofmann; P J Thomas
Journal:  Gastroenterology       Date:  1975-07       Impact factor: 22.682

5.  Chenodeoxycholic acid induced liver injury in pregnant and neonatal baboons.

Authors:  C K McSherry; K P Morrissey; R L Swarm; P S May; W H Niemann; F Glenn
Journal:  Ann Surg       Date:  1976-10       Impact factor: 12.969

6.  Impaired lithocholate sulfation in the rhesus monkey: a possible mechanism for chenodeoxycholate toxicity.

Authors:  T R Gadacz; R N Allan; E Mack; A F Hofmann
Journal:  Gastroenterology       Date:  1976-06       Impact factor: 22.682

7.  Serum bile acids as related to bile acid secretion in liver disease.

Authors:  E A Shaffer; E R Gordon
Journal:  Am J Dig Dis       Date:  1978-05

8.  Determinants of fasting and postprandial serum bile acid levels in healthy man.

Authors:  N F LaRusso; N E Hoffman; M G Korman; A F Hofmann; A E Cowen
Journal:  Am J Dig Dis       Date:  1978-05

9.  A radioimmunoassay of primary bile acid conjugates in human serum.

Authors:  A Roda; E Roda; D Festi; C Sama; G Mazzella; R Aldini; L Barbara
Journal:  Ric Clin Lab       Date:  1977 Apr-Jun

10.  Bile acid sulfates. I. Synthesis of lithocholic acid sulfates and their identification in human bile.

Authors:  R H Palmer; M G Bolt
Journal:  J Lipid Res       Date:  1971-11       Impact factor: 5.922

View more
  5 in total

1.  Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial.

Authors:  M J Veysey; P Malcolm; A I Mallet; P J Jenkins; G M Besser; G M Murphy; R H Dowling
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

Review 2.  Mechanisms of disease: Inborn errors of bile acid synthesis.

Authors:  Shikha S Sundaram; Kevin E Bove; Mark A Lovell; Ronald J Sokol
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-06-24

3.  Value of serum determinations for prediction of increased ursodeoxycholic and chenodeoxycholic levels in bile.

Authors:  F Bazzoli; H Fromm; A Roda; A K Tunuguntla; E Roda; L Barbara; P Amin
Journal:  Dig Dis Sci       Date:  1985-07       Impact factor: 3.199

Review 4.  Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

5.  Ursodeoxycholic acid in neonatal hepatitis and infantile paucity of intrahepatic bile ducts: review of a historical cohort.

Authors:  M A Kotb
Journal:  Dig Dis Sci       Date:  2008-12-10       Impact factor: 3.487

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.